← Back
$OTLK All transactions

Outlook Therapeutics, Inc.

A

$ Value

$0

Shares

800,000

Price

$0

Filed

Jul 9

Insider

Name

Jahr Robert Charles

Title

Chief Executive Officer

CIK

0002076177

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

800,000

Footnotes

25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date.

Filing Info

Accession No.

0001415889-25-019586

Form Type

4

Issuer CIK

0001649989

Jahr Robert Charles's History

Date Ticker Type Value
2025-07-01 OTLK A $0

Other Insiders at OTLK (90d)

No other insider activity at this issuer in the last 90 days.